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The coordination chemistry of 13 optically pure Pstereogenic diarylmonophosphanes P(Het)PhR [Het = 43 
4-dibenzofuranyl (DBF), 4-dibenzothiophenyl (DBT), 4-dibenzothiophenyl S,S-dioxide (DBTO2) and 44 
1-thianthrenyl (TA); R = OMe, Me, iPr, Fc (ferrocenyl)] to Pd-allyl moieties is described. Both neutral 45 
[PdCl(η3-(2-methylallyl)(κP-P)] and cationic [Pd{η3-(2-methylallyl)(κP-P)2}]PF6 complexes have 46 
been prepared. Coordination of the heteroatom of the heterocycle was only possible in the case of TA-47 
based phosphanes; these furnished complexes of the type [Pd{η3-(2-methylallyl)(κ2P,S-P)}]PF6 after 48 
chloride abstraction with TlPF6. The crystal structure of the complex [Pd(η3-2-methylallyl)(κ2P,S-49 
PPh(OMe)(1-TA)]PF6 is reported. The neutral Pd complexes were found to be highly active in the 50 
hydrovinylation of styrene after activation with AgBF4, except for the TAbased phosphanes. The 51 
cationic Pd complexes were evaluated in allylic alkylation and amination with the model substrate 52 






Although chiral diphosphanes are the most successful type of ligands of transition-metal homogeneous 59 
catalysis, for certain reactions or under certain conditions monophosphorus ligands can give better 60 
results or they can even be required, due to mechanistic restrictions. One example is the Ni- or Pd-61 
catalysed hydrovinylation of activated olefins.[1] 62 
In these processes, it is thought that secondary (hemilabile) interactions can play a crucial role, 63 
improving the activity and selectivity of the reaction. Several elegant examples have been provided by 64 
RajanBabu and co-workers[2] and by Franciò, Leitner and co-workers,[3] who convincingly 65 
demonstrated the importance of secondary interactions in Ni-catalysed hydrovinylation of olefins. The 66 
design of the ligand, however, is not easy, because it has to contain the appropriate Lewis base suitably 67 
located in the scaffold of the ligand to interact with the metal centre during the catalytic reaction. 68 
Very recently,[4] we described a series of monophosphorus, P-stereogenic ligands containing a 69 
heterocyclic substituent [4-dibenzofuryl (DBF), 4-dibenzothiophenyl (DBT), 4-dibenzothiophenyl 70 
(DBTO2) and 1-thianthrenyl (TA)] designed with the aim of disposing the heteroatom of the heterocycle 71 
in a suitable position allowing it to interact with the metal atom (Scheme 1). 72 
The coordination chemistry towards Ru–η6-arene moieties and the application of the complexes to 73 
transfer hydrogenation was also described. It was found that the sulfur atoms of DBTand TA-containing 74 
ligands were able to act in conjunction with phosphorus as bidentate ligands in a κ2P,S-coordinated 75 
fashion. 76 
In this paper we describe the coordination of these ligands to Pd–η3-allylic moieties and the application 77 
of the obtained complexes to catalytic hydrovinylation and allylic substitution reactions. 78 
.79 
RESULTS AND DISCUSSION 80 
 81 
Neutral Complexes 82 
As previously described for other monophosphanes,[5] treatment of the well-known Pd-dimer D with 83 
slightly more than two equivalents of phosphane in dichloromethane yielded the expected neutral 84 
complexes Pd1–13, of the type [PdCl(η3-2-methylallyl)(P)] (Scheme 2). 85 
The complexes were obtained as pale yellow solids, except for those containing phosphanes bearing the 86 
ferrocenyl group (Pd8 and Pd12), which were red. The complexes were characterised by IR, chemical 87 
microanalysis (or MS) and multinuclear NMR in solution. As expected,[5,6] the complexes were found 88 
to exist as mixtures of two diastereomeric species in solution, due to the presence of the chiral ligand 89 
and the allyl moiety. Hence, two singlets in the 31P{1H} NMR spectra, often partially overlapped, could 90 
be observed. All of the C and H atoms of the complexes are in principle different in each diastereomer; 91 
this could be clearly seen in the duplication of signals in the part corresponding to the allyl moiety in the 92 
1H and 13C NMR spectra of the complexes. Full details can be found in the Experimental Section. 93 
Integration of the 31P and 1H NMR spectra allows the estimation of the diastereomeric ratio in solution. 94 
It was found that this was approximately 1:1 for all complexes, except for Pd12, for which it was 1:1.2. 95 
Interestingly, in complexes bearing a phosphane containing the thianthryl group (Pd3 and Pd13) the H 96 
atoms of the allyl group gave rise to extremely wide peaks in the 1H NMR spectra. In addition, no peaks 97 
could be detected for the allyl group in the 13C{1H} spectra at room temperature. Low-temperature 1H 98 
NMR spectra of Pd13 in CD2Cl2 (see the Supporting Information) showed, however, that the expected 99 
allylic hydrogen atoms appeared when the spectrum was recorded at –80 °C. 100 
 101 
Cationic Complexes 102 
The next type of Pd complexes prepared were cationic bisphosphanes of the type [Pd(η3-2-103 
methylallyl)(P)2]PF6. As described in previous reports,[5,7] they were obtained by splitting dimer D 104 
with slightly more than four equivalents of phosphane in the presence of an excess of ammonium 105 
hexafluorophosphate (Scheme 3). 106 
The complexes were obtained as stable brown solids after extractive workup with water to remove 107 
inorganic salts. They were characterised by the usual techniques. The NMR spectra showed that a single 108 
species was present in solution, as previously found for analogous compounds.[5,7] The presence of the 109 
allyl group and the chirality of the phosphane makes it the case that the atoms in the molecule are all 110 
different. Therefore, two sharp doublets in the 31P{1H} NMR spectra corresponding to the two coupled 111 
phosphorus atoms (2JP,P = 30–57 Hz) could be observed. In the 13C NMR spectra the two terminal 112 
allyl carbon atoms appeared as doublets or doublets of doublets, due to the coupling with the P atoms of 113 
the phosphanes. The differences between the 13C chemical shifts of these two atoms are small (<2 114 
ppm), as found in similar complexes.[7] In the 1H NMR spectra, the four resonances of the allylic H 115 
atoms appeared as two broad singlets, corresponding to the syn protons and two doublets, corresponding 116 
to the anti protons (2JH,P = 9–12 Hz). The preparation of Pd4′ in pure form was not possible because it 117 
was always contaminated with around 25 % of neutral Pd4. 118 
We next moved to study of the coordinative interactions between the heterocycle and the Pd centre. 119 
Following our previous report with ruthenium,[4] we treated the neutral complexes Pd7 and Pd10 with 120 
thallium hexafluorophosphate in dichloromethane, and the solid obtained after the filtration of TlCl and 121 
removal of the solvent was analysed by NMR (Scheme 4). 122 
In the case of Pd7, no peaks appeared in the 31P NMR spectrum and the 1H NMR spectrum was broad 123 
and uninformative, indicating that no definite species were formed. In the case of the solid obtained 124 
from Pd10, both 31P and 1H NMR spectra showed that it corresponded to bis(phosphane) complex 125 
Pd10′. The formation of this compound indicates that a symmetrisation (disproportionation) reaction 126 
yielding the bis(phosphane) and the bis(solvato) complexes had taken place, as previously reported for 127 
Pd complexes with other monophosphane ligands.[7,8] 128 
In contrast to the unsuccessful attempts described above, the coordination of the S atom of the thianthryl 129 
group in complexes Pd3 and Pd13 was successfully accomplished, yielding cationic complexes Pd3′′ 130 
and Pd13′′ as pale yellow solids after recrystallisation (Scheme 5). It should be mentioned that the NMR 131 
of Pd13′′ shows the presence of a small quantity of bis(phosphane) complex Pd13′. 132 
The κ2P,S complexation of the ligands was confirmed by the downfield shift of the 31P signals 133 
[Δδ(Pd3′′–Pd3) = 26.2 ppm; Δδ(Pd13′′–Pd13) = 26.4 ppm] characteristic when a five-membered ring is 134 
formed.[9] Two peaks appeared in the 31P{1H} spectra and two sets of signals were present in the 1H 135 
and 13C{1H} spectra, indicating that complexes Pd3′′ and Pd13′′ exist as mixtures of the two 136 
diastereomers, as was also the case with precursor complexes Pd3 and Pd13. The ratio between the 137 
cationic complexes is roughly 60:40, meaning that the sulfur complexation step occurs with a small 138 
degree of diastereoselectivity. It is worth noting that complexes Pd3′′ and Pd13′′ showed well-defined 139 
NMR spectra. In the 1H and 13C{1H} NMR spectra, the expected two sets of peaks assignable to the 140 
allyl group appear, in contrast with the cases of Pd3 and Pd13 (vide infra). This is probably due to the 141 
rigid κ2P,S-coordination of the ligand in the cationic complexes. 142 
For complex Pd3′′, single crystals suitable for X-ray crystallography could be obtained. A representation 143 
of its molecular structure is given in Figure 1. 144 
The unit cell of Pd3′′ contains two independent molecules, corresponding to the two different isomers of 145 
the complex. They can be named as syn and anti with regard to the relative disposition between the 146 
methyl group of the allyl fragment and the methoxy group of the phosphinite. A particular feature of the 147 
structure is the expected[10] nonplanar, “butterfly“ shape of the thianthryl substituent of the phosphane, 148 
which is folded along its S–S axis. Interestingly, for both isomers in the crystal the thianthrene moiety is 149 
folded such that it remains parallel to the C(20)–C(22) bond of the allyl group. The Pd atom is in a 150 
distorted square-planar environment, the interatomic distances and angles of which are similar in the two 151 
isomers present in the unit cell and also similar to those in other Pd complexes containing five-152 
membered P,S chelate rings, such as in a complex with a 4-diphenylphosphinophenothiazine ligand 153 
described recently by Silaghi-Dumitrescu and co-workers.[11] The distance between the Pd atom and 154 
the C atom of the allyl group trans to the P atom is larger than with the C atom trans to the S atom, 155 
indicating a higher trans influence of the phosphinite group relative to the thioether group. It should be 156 
pointed out that the S atom coordinated to Pd is a stereogenic centre and that each of the molecules in 157 
the crystal structure has a different absolute configuration. 158 
The complexation studies described here with the Pd–η3-methallyl moiety can be compared with 159 
analogous recently described studies with the Ru–η6-arene moiety.[4] For the Ru systems it was found 160 
that both DBT- and TA-based phosphanes effectively coordinated to the Ru atom in a κ2P,S-mode but 161 
the DBF-based ligands did not. This shows that with the systems studied, the DBF-based phosphanes 162 
have the weakest tendency to act as bidentate ligands, whereas the TA-based ones show the strongest 163 
tendency. The softer character of sulfur relative to oxygen and the greater flexibility of the TA group 164 
relative to DBF and DBT probably account for the differences in coordination abilities of these ligands. 165 
 166 
Pd-Catalysed Hydrovinylation 167 
The hydrovinylation reaction is a catalysed heterocodimerisation between ethylene and a conjugated 168 
diene.[1b,1d] This reaction is interesting because it creates a C–C bond by using ethylene, which is an 169 
inexpensive feedstock, and because the double bond incorporated into the molecule can subsequently be 170 
manipulated in a multitude of ways. In addition, because a stereogenic centre is created, the reaction can 171 
be carried out enantioselectively.[1a,1c,1d] Despite its interest, activity and selectivity issues hamper its 172 
full development. The most typical catalytic systems involve a NiII or PdII precursor stabilised with a 173 
monophosphorus ligand because for these metals bidentate ligands inhibit the reaction.[2c] The presence 174 
of groups capable of establishing secondary coordination interactions with the metal can be beneficial 175 
for the reaction, as shown by RajanBabu and co-workers[2b,12] and by Leiner and co-workers[3a,13] in 176 
Ni-based systems. The catalytically active species is thought to be a metal hydride. In general, nickel 177 
systems are more commonly used because they are very active and can be highly enantioselective but 178 
with the penalty of requiring (usually)[3b] very low temperatures. In contrast, palladium-based systems 179 
work well at room temperature.[6,14] The challenge, apart from improving the enantioselectivity, is the 180 
control of the regioselectivity of the reaction, because the same hydrovinylation catalyst tends to 181 
isomerise the initially formed 3-arylbut-2-enes to the more stable 2-arylbut-2-enes. It has been found by 182 
us[5,6,8b,14b,15] and by others[14a] that [PdCl(η3-allyl)P] (P = monophosphorus ligand) complexes 183 
are excellent catalytic precursors of the active species after halide abstraction, so the potential of 184 
complexes Pd1–13 in hydrovinylation was explored (Scheme 6). 185 
The activation of the catalysts was carried out with silver tetrafluoroborate in the presence of styrene. 186 
After removal of silver chloride by filtration, the solution was pressurised with ethylene at 25 °C. The 187 
results obtained are given in Table 1. 188 
Most of the ligands produced active systems in the reaction but with very different activities depending 189 
on the substituents at the phosphorus atom. On close inspection, certain trends can be identified. In 190 
general the order of decreasing activity depending on the heterocycle is DBF >> DBT > DBTO2 >> TA; 191 
indeed, the two TA-based systems are completely inactive even at 6 h reaction time (Entries 3 and 13). 192 
This order correlates quite nicely with the coordination ability of the heteroatom in the heterocycle so it 193 
is not surprising that the two TA-based phosphanes give completely inactive systems given the fact that 194 
they act as true bidentate ligands, which are known to inhibit the hydrovinylation reaction.[2c] Within 195 
the DBF- and DBT-based families of ligands the order depending on the R substituent is tBu > iPr > Fc 196 
>> OMe ≈ Me, which means that, roughly, the bulkier the ligand the more active the system becomes. 197 
This trend contrasts with previous results obtained with diarylphosphanes.[15c] It can be observed that 198 
except for methoxy-and methylphosphanes (Entries 1–5, 10) the change of a polycyclic aryl 199 
group[5,6,15c,16] for a heterocyclic substituent makes the system much more active but less selective in 200 
the hydrovinylation reaction. With regard to the enantioselectivities, they are in the low range but 201 
comparable with those obtained with many previously reported diarylphosphanes.[5,6,15c,16] An 202 
interesting point is the inversion in the sense of enantioselection in comparison of analogous DBF and 203 
DBT phosphanes (cf. Entries 6 and 7 with 10 and 11, respectively) and in each family another inversion 204 
in comparison of the systems based on Fcphosphanes (Pd8 and Pd12) with their counterparts (cf. Entries 205 
6, 7 with 8, 10 and 11 with 12). 206 
 207 
Pd-Catalysed Allylic Substitution 208 
Asymmetric allylic substitution is a benchmark reaction very often used to test new ligands, especially 209 
bidentate ones.[17] In the asymmetric version the model substrate is rac-trans-1,3-diphenylprop-2-enyl 210 
acetate (rac-I)[18] and two of the most typically employed nucleophiles are the carbanion derived from 211 
dimethyl malonate (DMM, alkylation), formed in situ in the presence of bis(trimethylsilyl)acetamide 212 
(BSA) and potassium acetate,[19] and benzylamine (amination), as depicted in Scheme 7. 213 
In previous reports,[5,7] we employed Pd complexes of the type [Pd{η3-(2-214 
methylallyl)(PArPhR)2}]PF6 with P-stereogenic diarylphosphanes, obtaining complete conversions at 215 
24 h and up to 80 % ee in alkylation with a phosphinite ligand at room temperature. Table 2 gives the 216 
results obtained with the precursors presented in this paper. 217 
In the alkylation reaction, all the cationic and even neutral (Entries 4, 6, 11 and 13) Pd precursors led to 218 
full conversion after 24 h, giving the alkylation product with a wide range of enantiopurities depending 219 
on the substituents on the phosphorus ligand. It is clear that regardless of the heterocyclic substituent in 220 
the ligand those precursors containing phosphinites and methylphosphanes are bad enantioinductors 221 
(Entries 1–6 and 12), except for Pd13′, which is moderately enantioselective (Entry 16). With regard to 222 
the effect of the heterocycle, in general precursors with a DBF-containing ligands are less 223 
stereoselective, with the exception of Pd8′ (Entry 11). As expected, neutral complexes provide lower but 224 
still moderate levels of stereoselection (cf. Entry 13 with 14 and 16 with 17), in line with previously 225 
published results.[7,20] The best precursor is Pd11′ (Entry 13), the cationic complex with ligand L11. It 226 
is interesting to note that the same ligand was also the most stereoselective in transfer hydrogenation 227 
with Ru.[4] 228 
The sense of the enantioinduction in the alkylation product also depends on the substituents on the 229 
phosphane. It is S for most of the precursors, but the sense is inverted in the case of Fc- and TA- 230 
containing precursors, which give rise to the predominant formation of the R enantiomer of the 231 
alkylation product. As expected, neutral complexes provide lower but still moderate levels of 232 
stereoselection (cf. Entry 13 with 14 and 16 with 17), in line with previously published results.[7,20] 233 
In the case of allylic amination, full conversion is also reached with all the precursors except for cationic 234 
complexes Pd3′, Pd8′, Pd12′ and complex Pd6. As expected[5] the enantioselectivities are lower, but 235 




In this paper the coordination of 13 optically pure P-stereogenic diaryl monophosphinites and 240 
monophosphanes of the type PPh(Het)R (Het = 4-DBF, 4-DBT, 1-TA and 4-DBTO2; R = OMe, Me, 241 
iPr, tBu, Fc) to the Pd–η3-methallyl moiety has been studied. It has been found that the only ligands 242 
capable of acting as bidentate are those containing a 1-thianthrenyl group. The obtained Pd complexes 243 
were used in catalytic asymmetric hydrovinylation of styrene and allylic substitution on rac-I with the 244 
aim of comparing the performance of the new ligands with that of previously reported systems based on 245 
P-stereogenic PArPhR (Ar = polycyclic aromatic group).[5–7,15c,16] It was found that, in general, the 246 
new heterocyclic ligands give more active systems for the hydrovinylation reaction but that they are less 247 
selective towards 3-phenylbut-1-ene and none of them improves on the best enantioselectivity achieved 248 
with the previous systems. For the Pd-catalysed allylic substitution reactions, the activities and the best 249 




EXPERIMENTAL SECTION 254 
 255 
General: All compounds were prepared under purified nitrogen with use of standard Schlenk and 256 
vacuum-line techniques. The solvents were purified with a solvent purification system or by standard 257 
procedures[21] and kept under nitrogen. 1H, 13C{1H}, and 31P{1H} and HSQC 1H-13C NMR spectra 258 
were recorded with 300 and 400 MHz spectrometers and CDCl3 as solvent unless otherwise specified. 259 
In the NMR spectroscopic data for the Pd-methallyl complexes the following notation has been used: c 260 
(cis) and t (trans) with regard to the phosphorus moiety and s (syn) and a (anti) with regard to the methyl 261 
group of the methallyl moiety. IR spectra were recorded in KBr and the main absorption bands are 262 
expressed in cm–1. The results of elemental analyses were not accurate for all compounds, probably due 263 
to the presence of residual solvents (as shown in the NMR) or to bad combustion. In these cases, HRMS 264 
(carried out with use of electrospray ionisation) clearly reflected the purity of the complexes (see 265 
Supporting Information, with assignment of relevant peaks). Styrene hydrovinylation reactions were 266 
analysed by GC with He as a carrier gas. Allylic substitution reactions on trans-1,3-diphenylprop-2-enyl 267 
acetate (rac-I) were analysed by HPLC with a multidiode array detector and a OD-H chiral column (25 × 268 
0.46 cm). The eluent in the analyses was an n-hexane/iPrOH 95:5 mixture for the alkylations and a 99:1 269 
mixture for the aminations. Pd dimer D[22] and substrate rac-I[23] were prepared by literature 270 
procedures whereas other reagents were used as received from commercial suppliers. 271 
 272 
Synthesis of the Complexes 273 
[PdCl(η3-C4H7)(L1)] (Pd1): Phosphinite L1 (191 mg, 0.62 mmol) was dissolved in dichloromethane 274 
(20 mL), Pd dimer D (102 mg, 0.26 mmol) was added, and the yellow solution was stirred for 1 h. The 275 
solvent was removed under vacuum and the residue was recrystallized from dichloromethane/hexane, to 276 
furnish the title product as a pale yellow solid, yield 150 mg (57 %). 1H NMR (400 MHz): Eur. J. Inorg. 277 
Chem. 2016, 4216–4225 www.eurjic.org 4221 © 2016 Wiley-VCH Verlag GmbH & Co. KGaA, 278 
Weinheim δ = 8.07 (s, 1 H), 8.06 (s, 1 H), 7.97 (s, 1 H), 7.95 (s, 1 H), 7.91–7.86 (m, 4 H), 7.78–7.68 (m, 279 
2 H), 7.43–7.46 (m, 12 H), 7.38–7.34 (m, 4 H), 4.55 (s, 1 Hts), 4.53 (s, 1 Hts), 3.98 (d, 3JH,P = 14.0 Hz, 280 
3 H), 3.95 (d, 3JH,P = 12.0 Hz, 3 H), 3.63 (d, 3JH,P = 11.2 Hz, 1 Hta), 3.60 (d, 3JH,P = 11.6 Hz, 1 Hta), 281 
2.93 (s, 1 Hcs), 2.88 (s, 1 Hcs), 2.71 (s, 1 Hca), 2.70 (s, 1 Hca), 1.94 (s, 3 H), 1.91 (s, 3 H) ppm. 282 
13C{1H} NMR (101 MHz): δ = 155.9–111.8 (C, CH, Ar), 79.54 (d, 2JC,P = 37.3 Hz, CH2t), 79.36 (d, 283 
2JC,P = 37.1 Hz, CH2t), 59.2 (s, CH2c), 58.7 (s, CH2c), 57.0 (s, 2 × CH3), 23.2 (s, 2 × CH3) ppm. 284 
31P{1H} NMR (121 MHz): δ = +115.1 (s), +114.0 (s) ppm. IR: ν˜ = 3052, 2935, 2835, 1583, 1482, 285 
1468, 1435, 1402, 1185, 1108, 1029, 805, 757, 693 cm–1. HRMS: calcd. for C23H22O2PPd [M – Cl] 286 
467.0392; found 467.0397. 287 
 288 
[PdCl(η3-C4H7)(L2)] (Pd2): The procedure was the same as that used to prepare Pd1. Starting from L2 289 
(310 mg, 0.96 mmol) and dimer D (134 mg, 0.34 mmol) the desired complex was obtained as a 290 
yellowish solid, yield 157 mg (44 %). 1H NMR (400 MHz): δ = 8.27 (t, J = 1.2 Hz, 1 H), 8.25 (t, J = 1.2 291 
Hz, 1 H), 8.17 (m, 2 H), 7.93–7.80 (m, 4 H), 7.57 (br. m, 1 H), 7.49–7.41 (m, 7 H), 4.60 (s, 1 Hts), 4.58 292 
(s, 1 Hts), 3.95 (d, 3JH,P = 14.0 Hz, 3 H), 3.91 (d, 3JH,P = 14.0 Hz, 3 H), 3.68 (d, 3JH,P = 11.2 Hz, 2 293 
Hta), 2.91 (br. s, 1 Hcs), 2.84 (br. s, 1 Hcs), 2.70 (br. s, 1 Hca), 2.65 (br. s, 1 Hca), 1.94 (s, 3 H), 1.91 (s, 294 
3 H) ppm. 13C{1H} NMR (101 MHz): δ = 134.3–121.6 (C, CH, Ar), 80.5 (d, 2JC,P = 18.3 Hz, CH2 t), 295 
80.2 (d, 2JC,P = 19.0 Hz, CH2 t), 59.1 (s, CH2 c), 58.8 (s, CH2 c), 56.7 (s, 2 × CH3), 23.34 (s, CH3), 296 
23.27 (s, CH3) ppm. 31P{1H} NMR (162 MHz): δ = +119.8 (s), +118.8 (s) ppm. IR: ν˜ = 3051, 2933, 297 
2835, 1436, 1376, 1103, 1079, 1028, 805, 754, 693, 585, 555 cm–1. C23H22ClOPPdS (519.31): calcd. 298 
C 53.19, H 4.27, S 6.17; found C 52.74, H 4.52, S 5.74. 299 
 300 
[PdCl(η3-C4H7)(L3)] (Pd3): The procedure was the same as that used to prepare Pd1. Starting from L3 301 
(220 mg, 0.62 mmol) and dimer D (87 mg, 0.22 mmol) the desired complex was obtained as a pale 302 
yellow solid, yield 220 mg (91 %). 1H NMR (400 MHz): δ = 7.97 (dd, J = 7.6, 1.6 Hz, 1 H), 7.94 (dd, J 303 
= 7.2, 2.0 Hz, 1 H), 7.63– 7.56 (m, 2 H), 7.47–7.35 (m, 6 H), 7.24–7.20 (m, 2 H), 3.88 (d, 3JH,P = 14.0 304 
Hz, 3 H) ppm. 31P{1H} NMR (162 MHz): δ = +111.2 (br. s) ppm. IR: ν˜ = 3058, 2923, 1634, 1435, 305 
1382, 1101, 1028, 777, 744, 693, 569, 549, 495 cm–1. C23H22ClOPPdS2 (551.37): calcd. C 50.10, H 306 
4.02, S 11.63; found C 50.40, H 4.21, S 11.88. 307 
 308 
[PdCl(η3-C4H7)(L4)] (Pd4): The procedure was the same as that used to prepare Pd1. Starting from L4 309 
(74 mg, 0.21 mmol) and dimer D (35 mg, 0.088 mmol) the desired complex was obtained as a yellow 310 
solid, yield 70 mg (72 %). 1H NMR (400 MHz): δ = 8.09– 8.02 (m, 4 H), 7.84–7.78 (m, 6 H), 7.67–7.62 311 
(m, 6 H), 7.58–7.46 (m, 12 H), 4.60 (dd, J = 7.5, 3.2 Hz, 1 Hts), 4.57 (dd, J = 7.5, 3.2 Hz, 1 Hts), 3.93 312 
(d, 3JH,P = 14.0 Hz, 3 H), 3.92 (d, 3JH,P = 14.0 Hz, 3 H), 3.67 (d, 3JH,P = 11.2 Hz, 1 Hta), 3.62 (d, 313 
3JH,P = 10.8 Hz, 1 Hta), 3.41 (br. s, 1 Hcs), 3.33 (br. s, 1 Hcs), 2.96 (s, 1 Hca), 2.69 (s, 1 Hca), 2.01 (s, 314 
3 H), 1.91 (s, 3 H) ppm. 13C{1H} NMR (101 MHz): δ = 156.4–121.3 (C, CH, Ar), 80.5 (d, 2JC,P = 315 
12.0 Hz, CH2 t), 80.2 (d, 2JC,P = 12.7 Hz, CH2 t), 59.1 (d, 2JC,P = 2.3 Hz, CH2 c), 58.5 (d, 2JC,P = 2.8 316 
Hz, CH2 c), 57.5 (d, 2JC,P = 2.7 Hz, CH3), 56.9 (d, 2JC,P = 1.9 Hz, CH3), 23.3 (s, 2 × CH3) ppm. 317 
31P{1H} NMR (162 MHz): δ = 126.0 (s), 124.7 (s) ppm. IR: ν˜ = 3052, 2938, 1437, 1309, 1159, 1044, 318 
764, 584, 568, 543 cm–1. HRMS: calcd. for C23H22O3PPdS [M – Cl] 515.0056; found 515.0079. 319 
 320 
[PdCl(η3-C4H7)(L5)] (Pd5): The procedure was the same as that used to prepare Pd1. Starting from L5 321 
(189 mg, 0.65 mmol) and dimer D (106 mg, 0.27 mmol) the desired complex was obtained as a yellow 322 
solid, yield 204 mg (78 %). 1H NMR (400 MHz): δ = 8.06 (t, J = 1.2 Hz, 1 H), 8.04 (t, J = 0.8 Hz, 1 H), 323 
7.98 (s, 1 H), 7.97–7.96 (m, 2 H), 7.95 (m, 1 H), 7.72–7.64 (m, 4 H), 7.58 (s, 1 H), 7.56 (s, 1 H), 7.51–324 
7.32 (m, 12 H), 4.47 (s, 1 Hts), 4.45 (s, 1 Hts), 3.50 (d, 3JH,P = 10.0 Hz, 1 Hta), 3.48 (d, 3JH,P = 10.4 325 
Hz, 1 Hta), 2.94 (s, 1 Hcs), 2.87 (s, 1 Hcs), 2.66 (s, 1 Hca), 2.58 (s, 1 Hca), 2.35 (d, 2JH,P = 8.8 Hz, 3 326 
H), 2.33 (d, 2JH,P = 9.2 Hz, 3 H), 1.95 (s, 3 H), 1.85 (s, 3 H) ppm. 13C{1H} NMR (101 MHz): δ = 327 
155.9–111.6 (C, CH, Ar), 76.9 (d, ov, CH2 t), 76.5 (d, ov, CH2 t), 58.9 (s, 2 × CH2 c), 23.44 (s, CH3), 328 
23.36 (s, CH3), 12.4 (m, 2 × CH3) ppm. 31P{1H} NMR (121 MHz): δ = +5.3 (s), +4.9 (s) ppm. IR: ν˜ = 329 
3050, 2979, 2915, 1583, 1469, 1448, 1435, 1399, 1184, 894, 840, 754, 692, 554, 422 cm–1. 330 
C23H22ClOPPd (487.25): calcd. C 56.69, H 4.55; found C 57.32, H 4.78. 331 
 332 
[PdCl(η3-C4H7)(L6)] (Pd6): The procedure was the same as that used to prepare Pd1. Starting from L6 333 
(318 mg, 1.00 mmol) and dimer D (141 mg, 0.36 mmol) the desired complex was obtained as a yellow 334 
solid, yield 280 mg (75 %). 1H NMR (400 MHz): δ = 8.06 (s, 1 H), 8.04 (s, 1 H), 7.97 (s, 1 H), 7.95 (s, 335 
1 H), 7.83 (dd, J = 10.8, 7.6 Hz, 1 H), 7.75–7.65 (m, 6 H), 7.49–7.34 (m, 13 H), 4.44 (dd, J = 6.8, 3.2 336 
Hz, 1 Hts), 4.42 (dd, J = 6.8, 3.2 Hz, 1 Hts), 3.53–3.41 (m, 2 H), 3.51 (d, 3JH,P = 9.6 Hz, 1 Hta), 3.47 337 
(d, 3JH,P = 10.0 Hz, 1 Hta), 3.05 (m, 1 Hcs), 2.96 (m, 1 Hcs), 2.59 (br. s, 2 Hca), 1.91 (s, 3 H), 1.77 (s, 338 
3 H), 1.34–1.19 (m, 12 H) ppm. 13C{1H} NMR (101 MHz): δ = 156.5–111.7 (C, CH, Ar), 77.70 (d, 339 
2JC,P = 32.4 Hz, CH2 t), 77.67 (d, 2JC,P = 32.7 Hz, CH2 t), 59.7 (s, CH2 c), 59.0 (s, CH2 c), 24.9 (d, 340 
1JC,P = 18.1 Hz, CH), 24.7 (d, 1JC,P = 18.2 Hz, CH), 23.2 (s, CH3), 23.0 (s, CH3), 19.2 (s, CH3), 19.1 341 
(s, CH3), 18.6 (d, 2JC,P = 1.3 Hz, CH3), 18.4 (s, CH3) ppm. 31P{1H} NMR (121 MHz): δ = +28.0 (s), 342 
+27.1 (s) ppm. IR: ν˜ = 3051, 2957, 2925, 2867, 1582, 1469, 1449, 1435, 1401, 1184, 757, 697, 536 343 
cm–1. C25H26ClOPPd (515.31): calcd. C 58.27, H 5.09; found C 59.68, H 5.54. 344 
 345 
[PdCl(η3-C4H7)(L7)] (Pd7): The procedure was the same as that used to prepare Pd1. Starting from L7 346 
(203 mg, 0.61 mmol) and dimer D (98 mg, 0.25 mmol) the desired complex was obtained as a yellow 347 
solid, yield 150 mg (57 %). 1H NMR (300 MHz): δ = 8.07–7.86 (m, 9 H), 7.78 (ddd, J = 10.5, 7.8, 1.2 348 
Hz, 1 H), 7.49–7.34 (m, 14 H), 4.45–4.40 (m, 2 Hts), 3.53 (d, J = 9.7 Hz, 2 Hta), 2.43 (s, 1 Hcs), 2.25 (s, 349 
1 Hcs), 2.16 (m, 1 Hca), 2.12 (s, 1 Hca), 1.80 (s, 3 H), 1.73 (s, 3 H), 1.54 (d, 3JH,P = 15.8 Hz, 9 H), 1.50 350 
(d, 3JH,P = 15.9 Hz, 9 H) ppm. 13C{1H} NMR (101 MHz): δ = 156.1–111.8 (C, CH, Ar), 78.3 (d, 351 
2JC,P = 31.2 Hz, CH2 t), 78.0 (d, 2JC,P = 31.5 Hz, CH2 t), 61.8 (s, CH2 c), 61.4 (s, CH2 c), 34.9 (d, 352 
1JC,P = 17.7 Hz, C), 34.5 (d, 1JC,P = 17.9 Hz, C), 29.26 (d, 2JC,P = 3.0 Hz, CH3), 29.20 (d, 2JC,P = 353 
3.2 Hz, CH3), 22.94 (s, 2 × CH3) ppm. 31P{1H} NMR (121 MHz): δ = +35.7 (s) ppm. IR: ν˜ = 3051, 354 
2956, 2924, 1581, 1469, 1449, 1434, 1398, 1185, 1109, 756, 698 cm–1. C26H28ClOPPd (529.33): 355 
calcd. C 58.99, H 5.33; found C 59.42, H 5.78. 356 
 357 
[PdCl(η3-C4H7)(L8)] (Pd8): The procedure was the same as that used to prepare Pd1. Starting from L8 358 
(69 mg, 0.15 mmol) and dimer D (25 mg, 0.064 mmol) the desired complex was obtained as a reddish 359 
solid, yield 76 mg (90 %). 1H NMR (400 MHz): δ = 8.04–8.02 (m, 2 H), 7.97 (br. s, 1 H), 7.95 (br. s, 1 360 
H), 7.75–7.69 (m, 4 H), 7.45–7.30 (m, 14 H), 7.27 (m, 1 H), 4.81 (s, 1 H), 4.70 (s, 1 H), 4.53 (m, 2 Hts), 361 
4.49 (s, 1 H), 4.47 (s, 1 H), 4.44 (s, 2 H), 4.35 (s, 1 H), 4.28 (s, 1 H), 4.243 (s, 5 H), 4.237 (s, 5 H), 3.65 362 
(d, 3JH,P = 10.4 Hz, Hta),  3.62 (d, 3JH,P = 10.8 Hz, Hta), 2.90 (s, 1 Hcs), 2.83 (s, 1 Hca), 2.76 (s, 1 363 
Hcs), 2.58 (s, 1 Hca), 1.99 (s, 3 H), 1.88 (s, 3 H) ppm. 13C{1H} NMR (101 MHz): δ = 155.7–111.7 (C, 364 
CH, Ar), 78.5 (d, 2JC,P = 33.6 Hz, CH2 t), 77.9 (d, 2JC,P = 33.6 Hz, CH2 t), 75.3 (d, J = 15.6 Hz, CH), 365 
75.1 (d, J = 15.5 Hz, CH), 73.9 (d, J = 8.9 Hz, CH), 73.8 (d, J = 9.1 Hz, CH), 70.1 (s, 10 CH), 61.6 (s, 366 
CH2 c), 60.1 (s, CH2 c), 23.14 (s, CH3), 23.10 (s, CH3) ppm. 31P{1H} NMR (162 MHz): δ = +6.2 (s), 367 
+6.1 (s) ppm. IR: ν˜ = 3087, 3050, 2958, 1618, 1469, 1448, 1403, 1265, 1184, 1166, 1108, 751, 698 368 
cm–1. HRMS: calcd. for C32H28FeOPPd [M – Cl] 621.0256; found 621.0275. 369 
 370 
[PdCl(η3-C4H7)(L9)] (Pd9): The procedure was the same as that used to prepare Pd1. Starting from L9 371 
(150 mg, 0.33 mmol) and dimer D (52 mg, 0.13 mmol) the desired complex was obtained as a yellow 372 
solid, yield 160 mg (93 %). 1H NMR (400 MHz): δ = 8.27 (t, J = 1.6 Hz, 1 H), 8.25 (t, J = 1.6 Hz, 1 H), 373 
8.19 (s, 1 H), 8.17 (s, 1 H), 8.11–7.97 (m, 8 H), 7.75–7.02 (m, 2 H), 7.49–7.31 (m, 24 H), 4.55 (m, 2 374 
Hts), 3.69 (d, 3JH,P = 10.0 Hz, 1 Hta), 3.66 (d, 3JH,P = 10.0 Hz, 1 Hta), 3.05 (s, 1 Hcs), 2.86 (s, 1 Hcs), 375 
2.82 (s, 1 Hca), 2.70 (s, 1 Hca), 2.01 (s, 3 H), 1.97 (s, 3 H) ppm. 13C{1H} NMR (101 MHz): δ = 155.7– 376 
111.7 (C, CH, Ar), 78.1 (d, 2JC,P = 32.9 Hz, CH2 t), 77.8 (d, 2JC,P = 32.9 Hz, CH2 t), 62.8 (s, CH2 c), 377 
62.6 (s, CH2 c), 23.06 (s, 2 × CH3) ppm. 31P{1H} NMR (162 MHz): δ = +10.4 (s), +9.3 (s) ppm. IR: ν˜ 378 
= 3052, 1618, 1581, 1468, 1448, 1436, 1402, 1377, 1185, 1108, 800, 752, 656, 541 cm–1. HRMS: 379 
calcd. for C34H26OPPdS [M – Cl] 619.0471; found 619.0494. C34H26ClOPPdS (655.47): calcd. C 380 
62.30, S 4.89, H 4.00; found C 61.86, S 4.13, H 4.38. 381 
 382 
[PdCl(η3-C4H7)(L10)] (Pd10): The procedure was the same as that used to prepare Pd1. Starting from 383 
L10 (260 mg, 0.85 mmol) and dimer D (130 mg, 0.33 mmol) the desired complex was obtained as a pale 384 
yellow solid, yield 200 mg (60 %). 1H NMR (400 MHz): δ = 8.24–8.22 (m, 2 H), 8.18–8.16 (m, 2 H), 385 
7.79 (br. m, 2 H), 7.72–7.67 (m, 4 H), 7.56–7.43 (m, 14 H), 4.55 (m, 1 Hts), 4.52 (m, 1 Hts), 3.57 (d, 386 
3JH,P = 10.0 Hz, 2 Hta), 2.95 (s, 2 Hcs), 2.67 (s, 1 Hca), 2.55 (s, 1 Hca), 2.28 (d, 2JH,P = 8.7 Hz, 3 H), 387 
2.26 (d, 2JH,P = 8.7 Hz, 3 H), 1.94 (s, 3 H), 1.91 (s, 3 H) ppm. 13C{1H} NMR (101 MHz): δ = 134.6–388 
121.7 (C, CH, Ar), 77.8 (d, 2JC,P = 33.4 Hz, 2 × CH2 t), 59.1 (s, CH2 c), 58.6 (s, CH2 c), 23.3 (s, 2 × 389 
CH3), 12.2 (d, 1JC,P = 27.0 Hz, CH3), 11.9 (d, 1JC,P = 27.1 Hz, CH3) ppm. 31P{1H} NMR (162 390 
MHz): δ = +8.6 (s), +8.2 (s) ppm. IR: ν˜ = 3050, 2956, 2913, 1450, 1376, 1104, 1034, 892, 754, 693, 391 
520 cm–1. C23H22ClPPdS (503.31): calcd. C 54.88, H 4.41, S 6.37; found C 54.29, H 4.66, S 5.88. 392 
 393 
[PdCl(η3-C4H7)(L11)] (Pd11): The procedure was the same as that used to prepare Pd1. Starting from 394 
L11 (461 mg, 1.38 mmol) and dimer D (181 mg, 0.46 mmol) the desired complex was obtained as a 395 
yellow solid, yield 255 mg (52 %). 1H NMR (400 MHz): δ = 8.26–8.23 (m, 2 H), 8.17–8.14 (m, 2 H), 396 
7.85 (t, J = 8.4 Hz, 1 H), 7.78–7.73 (m, 6 H), 7.62–7.57 (m, 3 H), 7.47–7.35 (m, 10 H), 4.50 (m, 2 Hts), 397 
3.60 (d, 3JH,P = 9.2 Hz, 1 Hta), 3.53 (d, 3JH,P = 9.2 Hz, 1 Hta), 3.53–3.24 (m, 2 H), 2.95 (br. s, 1 Hcs), 398 
2.68 (br. s, 1 Hcs), 2.64 (s, 1 Hca), 2.49 (s, 1 Hca), 1.82 (s, 6 H), 1.41 (dd, J = 6.8, 4.0 Hz, 3 H), 1.36 399 
(dd, J = 7.2, 4.4 Hz, 3 H), 1.25 (dd, J = 16.4, 6.8 Hz, 3 H), 1.18 (dd, J = 16.4, 6.8 Hz, 3 H) ppm. 400 
13C{1H} NMR (101 MHz): δ = 139.4–121.6 (C, CH, Ar), 79.1 (d, 2JC,P = 31.3 Hz, CH2 t), 78.5 (d, 401 
2JC,P = 31.0 Hz, CH2 t), 60.3 (s, CH2 c), 58.9 (s, CH2 c), 25.7 (d, 1JC,P = 23.3 Hz, CH), 25.1 (d, 1JC,P 402 
= 23.6 Hz, CH), 22.96 (s, CH3), 22.86 (s, CH3), 19.9 (d, 2JC,P = 6.9 Hz, CH3), 19.8 (d, 2JC,P = 5.9 Hz, 403 
CH3), 18.5 (d, 2JC,P = 2.3 Hz, CH3), 18.3 (s, CH3) ppm. 31P{1H} NMR (162 MHz): δ = +28.2 (s), 404 
+28.1 (s) ppm. IR: ν˜ = 3048, 2958, 2925, 2866, 1435, 1374, 1097, 1079, 1034, 751, 697, 659, 585, 542, 405 
466 cm–1. HRMS: calcd. for C25H26PPdS [M – Cl] 495.0522; found 495.0542. 406 
 407 
[PdCl(η3-C4H7)(L12)] (Pd12): The procedure was the same as that used to prepare Pd1. Starting from 408 
L12 (60 mg, 0.13 mmol) and dimer D (21 mg, 0.053 mmol) the desired complex was obtained as a red 409 
solid, yield 68 mg (95 %). 1H NMR (400 MHz): δ = 8.19–8.13 (m, 2 H, M + m), 8.10–8.02 (m, 2 H, M 410 
+ m), 7.77–7.73 (m, 1 H, M + m), 7.48–7.41 (m, 6 H, M + m), 7.22 (dd, J = 10.4, 7.6 Hz, 1 H, m), 7.13 411 
(dd, J = 10.4, 7.2 Hz, 1 H, M), 4.86 (br. s, 1 H, m), 4.75 (br. s, 1 H, M), 4.63 (dd, J = 6.4, 3.2 Hz, 1 Hts, 412 
M), 4.59 (br. s, 2 H, m), 4.56 (dd, J = 6.8, 3.2 Hz, 1 Hts, m), 4.49–4.47 (m, 2 H, M), 4.29 (s, 5 H, m), 413 
4.28 (s, 5 H, M), 3.98 (br. s, 1 H, m), 3.92 (br. s, 1 H, M), 3.71 (d, 3JH,P = 9.6 Hz, 1 Hta, M), 3.67 (d, 414 
3JH,P = 10.0 Hz, Hta, m), 2.89 (br. s, 1 Hcs, M), 2.80 (br. s, 1 Hcs, m), 2.39 (br. s, 1 Hca, m), 2.15 (br. 415 
s, 1 Hca, M), 2.07 (s, 3 H, M), 1.62 (s, 3 H, m) ppm. 13C{1H} NMR (101 MHz): δ = 134.6–121.6 (C, 416 
CH, Ar), 80.0 (d, 2JC,P = 32.7 Hz, CH2 t, M), 78.6 (d, 2JC,P = 32.3 Hz, CH2 t, m), 76.1 (s, CH), 75.9 417 
(s, CH), 72.2–71.5 (m, 6 × CH), 70.14 (s, 5 × CH, m), 70.09 (s, 5 × CH, M), 61.4 (d, 2JC,P = 1.9 Hz, 418 
CH2 c, m), 59.5 (s, CH2 c, M), 23.0 (s, CH3, M), 22.9 (s, CH3, m) ppm. 31P{1H} NMR (162 MHz): δ 419 
= +9.4 (s, M), +9.0 (s, m) ppm. IR: ν˜ = 3048, 2958, 1437, 1378, 1272, 1167, 1108, 1097, 1078, 1023, 420 
821, 754, 736, 585, 551, 498, 478, 456, 425 cm–1. HRMS: calcd. For C32H28FePPdS [M – Cl] 421 
637.0028; found 637.0040. 422 
 423 
[PdCl(η3-C4H7)(L13)] (Pd13): The procedure was the same as that used to prepare Pd1. Starting from 424 
L13 (281 mg, 0.83 mmol) and dimer D (130 mg, 0.33 mmol) the desired complex was obtained as a 425 
yellow solid, yield 280 mg (79 %). 1H NMR (400 MHz): δ = 7.71 (dd, J = 7.6, 1.6 Hz, 1 H), 7.68 (dd, J 426 
= 7.6, 1.6 Hz, 1 H), 7.59 (dt, J = 7.6, 1.2 Hz, 1 H), 7.51–7.41 (m, 4 H), 7.35 (dd, J = 7.2, 1.6 Hz, 1 427 
H),7.28–7.17 (m, 4 H), 2.22 (d, 2JH,P = 8.8 Hz, 3 H), 1.91 (s, 3 H) ppm. 13C{1H} NMR (101 MHz): δ 428 
= 139.2–127.2 (C, CH, Ar), 23.2 (s, 2 × CH3), 13.4 (d, 1JC,P = 27.1 Hz, CH3) ppm. 31P{1H} NMR 429 
(162 MHz): δ = +8.9 (br. s) ppm. IR: ν˜ = 3048, 2956, 2911, 1616, 1448, 1434, 1380, 1140, 1101, 1027, 430 
891, 836, 749, 692, 487, 444 cm–1. HRMS: calcd. For C23H22PPdS2 [M – Cl] 498.9929; found 431 
498.9937. C23H22ClPPdS2 (535.37): calcd. C 51.60, S 11.98, H 4.14; found C 50.33, S 11.00, H 4.44. 432 
 433 
[Pd(η3-C4H7)(L1)2]PF6 (Pd1′): Phosphinite L1 (323 mg, 1.05 mmol), Pd dimer D (70 mg, 0.18 mmol) 434 
and NH4PF6 (171 mg, 1.05 mmol) were suspended in dichloromethane (20 mL) and stirred vigorously 435 
for 2 h. Water (20 mL) was added and the mixture was extracted with dichloromethane (3 × 10 mL). 436 
The combined organic phase was washed with water, dried with anhydrous Na2SO4 and filtered, and 437 
the solvent was removed under vacuum. The crude product was recrystallised from 438 
dichloromethane/hexane, yield 204 mg (62 %). 1H NMR (400 MHz): δ = 8.00–7.89 (m, 4 H), 7.58–7.20 439 
(m, 19 H), 7.07 (ddd, J = 10.4, 7.6, 1.2 Hz, 1 H), 4.06 (d, J = 5.6 Hz, 1 Hs), 4.04 (d, J = 5.6 Hz, 1 Hs), 440 
3.66 (d, 3JH,P = 13.2 Hz, 3 H), 3.60 (d, 3JH,P = 13.2 Hz, 3 H), 3.47 (d, 3JH,P = 10.8 Hz, 1 Ha), 3.39 (d, 441 
3JH,P = 10.8 Hz, 1 Ha), 1.80 (s, 3 H) ppm. 13C{1H} NMR (101 MHz): δ = 155.6–111.5 (C, CH, Ar), 442 
74.7 (dd, JC,P = 23.0, 3.6 Hz, CH2), 74.4 (dd, JC,P = 25.0, 3.3 Hz, CH2), 56.9 (d, 2JC,P = 6.0 Hz, 443 
CH3), 56.8 (d, 2JC,P = 6.6 Hz, CH3), 23.7 (s, CH3) ppm. 31P{1H} NMR (162 MHz): δ = +113.6 (d, 444 
2JP,P = 56.5 Hz), +112.4 (d, 2JP,P = 56.5 Hz) ppm. IR: ν˜ = 3061, 2956, 2872, 1585, 1469, 1448, 1404, 445 
1264, 1185, 1110, 1035, 839 [ν(PF6 –)], 756, 695, 557 cm–1. C42H37F6O4P3Pd (919.06): calcd. C 446 
54.89, H 4.06; found C 56.52, H 4.98. 447 
 448 
[Pd(η3-C4H7)(L2)2]PF6 (Pd2′): The procedure was the same as that used to prepare Pd1′. Starting from 449 
L2 (273 mg, 0.85 mmol) and dimer D (56 mg, 0.14 mmol) the desired complex was obtained as a brown 450 
solid, yield 177 mg (66 %). 1H NMR (400 MHz): δ = 8.18– 8.08 (m, 4 H), 7.86 (m, 1 H), 7.60–7.30 (m, 451 
19 H), 4.32 (br. s, 1 Hs), 4.02 (br. s, 1 Hs), 3.52 (d, 3JH,P = 11.6 Hz, 1 Ha), 3.49 (d, 3JH,P = 10.4 Hz, 1 452 
Ha), 3.47 (d, 3JH,P = 12.4 Hz, 3 H), 3.43 (d, 3JH,P = 12.4 Hz, 3 H), 1.87 (s, 3 H) ppm. 13C{1H} NMR 453 
(101 MHz): δ = 141.6–121.5 (C, CH, Ar), 74.9 (dd, JC,P = 2.8, 2.7 Hz, CH2), 74.6 (dd, JC,P = 2.8, 2.7 454 
Hz, CH2), 55.8 (d, 2JC,P = 2.1 Hz, CH3), 55.7 (d, 2JC,P = 2.1 Hz, CH3), 23.7 (s, CH3) ppm. 31P{1H} 455 
NMR (162 MHz): δ = +122.3 (d, 2JP,P = 55.4 Hz), +119.0 (d, 2JP,P = 54.6 Hz) ppm. IR: ν˜ = 3056, 456 
2940, 1437, 1377, 1104, 1021, 841 [ν(PF6 –)], 750, 702, 557 cm–1. HRMS: calcd. For 457 
C42H37O2P2PdS2 [M – PF6] 805.0739; found 805.0755. 458 
 459 
[Pd(η3-C4H7)(L3)2]PF6 (Pd3′): The procedure was the same as that used to prepare Pd1′. Starting from 460 
L3 (350 mg, 0.99 mmol) and dimer D (70 mg, 0.18 mmol) the desired complex was obtained as a brown 461 
solid, yield 300 mg (82 %). 1H NMR (400 MHz): δ = 7.62– 7.06 (br. m, 23 H), 6.78 (br. s, 1 H), 4.19 462 
(br. s, 2 Hs), 3.54 (br. d, 3JH,P = 9.2 Hz, 3 H), 3.43 (d, 3JH,P = 11.2 Hz, 3 H), 3.33 (br. s, 2 Ha), 2.03 (s, 463 
3 H) ppm. 31P{1H} NMR (162 MHz): δ = +114.5 (d, 2JP,P = 56.2 Hz), +112.3 (d, 2JP,P = 56.1 Hz) 464 
ppm. IR: ν˜ = 3054, 2945, 2838, 1450, 1435, 1382, 1251, 1140, 1102, 1027, 832 [ν(PF6 –)], 747, 696, 465 
558 cm–1. C42H37F6O2P3PdS4 (1015.30): calcd. C 49.68, H 3.67, S 12.63; found C 51.89, H 3.03, S 466 
11.76. 467 
 468 
[Pd(η3-C4H7)(L5)2]PF6 (Pd5′): The procedure was the same as that used to prepare Pd1′. Starting from 469 
L5 (80 mg, 0.28 mmol) and dimer D (22 mg, 0.06 mmol) the desired complex was obtained as a 470 
brownish solid, yield 86 mg (87 %). 1H NMR (400 MHz): δ = 7.89–7.79 (m, 4 H), 7.51–7.30 (m, 16 H), 471 
7.14–6.98 (m, 3 H), 6.68 (dd, J = 11.6, 7.6 Hz, 1 H), 3.95 (s, 1 Hs), 3.70 (s, 1 Hs), 3.51 (d, 3JH,P = 10.0 472 
Hz, 1 Ha), 3.44 (d, 3JH,P = 10.0 Hz, 1 Ha), 2.18 (d, 2JH,P = 8.4 Hz, 3 H), 1.99 (d, 2JH,P = 8.8 Hz, 3 H), 473 
1.85 (s, 3 H) ppm. 13C{1H} NMR (101 MHz): δ = 155.5–111.6 (C, CH, Ar), 75.0 (d, JC,P = 29.4 Hz, 474 
CH2), 74.2 (d, JC,P = 30.6 Hz, CH2), 23.8 (s, CH3), 14.8 (dd, 1JC,P = 28.1, 1.1 Hz, CH3), 13.3 (dd, 475 
1JC,P = 28.0, 1.9 Hz, CH3) ppm. 31P{1H} NMR (162 MHz): δ = +0.2 (d, 2JP,P = 40.5 Hz), –0.1 (d, 476 
2JP,P = 40.5 Hz) ppm. IR: ν˜ = 3062, 2957, 2923, 1584, 1470, 1450, 1437, 1403, 1186, 1111, 1010, 896, 477 
843 [ν(PF6 –)], 754, 634, 557 cm–1. HRMS: calcd. for C42H37O2P2Pd [M – PF6], 741.1304; found 478 
741.1326. 479 
 480 
[Pd(η3-C4H7)(L6)2]PF6 (Pd6′): The procedure was the same as that used to prepare Pd1′. Starting from 481 
L6 (370 mg, 1.16 mmol) and dimer D (85 mg, 0.22 mmol) the desired complex was obtained as a dark 482 
yellow solid, yield 290 mg (71 %). 1H NMR (400 MHz): δ = 8.01–7.95 (m, 4 H), 7.48–7.21 (m, 18 H), 483 
7.16–7.11 (m, 2 H), 4.27 (br. s, 1 Hs), 4.21 (br. s, 1 Hs), 3.42 (d, 3JH,P = 9.6 Hz, 1 Ha), 3.31 (d, 3JH,P = 484 
9.6 Hz, 1 Ha), 2.96 (m, 1 H), 2.78 (m, 1 H), 1.74 (s, 3 H), 0.99–0.83 (m, 12 H) ppm. 13C{1H} NMR 485 
(101 MHz): δ = 156.0–111.4 (C, CH, Ar), 75.0 (d, JC,P = 28.4 Hz, CH2), 74.7 (d, JC,P = 28.4 Hz, 486 
CH2), 28.0 (d, 1JC,P = 23.4 Hz, CH), 26.7 (d, 1JC,P = 23.5 Hz, CH), 23.0 (s, CH3), 19.3 (d, 2JC,P = 3.8 487 
Hz, CH3), 19.1 (d, 2JC,P = 3.6 Hz, CH3), 19.0 (d, 2JC,P = 2.4 Hz, 2 × CH3) ppm. 31P{1H} NMR (162 488 
MHz): δ = +25.0 (d, 2JP,P = 34.2 Hz), +23.7 (d, 2JP,P = 34.2 Hz) ppm. IR: ν˜ = 3065, 2960, 2929, 489 
2870, 1583, 1469, 1450, 1435, 1402, 1264, 1185, 1111, 1037, 839 [ν(PF6 –)], 757, 697, 557 cm–1. 490 
C46H45F6O2P3Pd (943.17): calcd. C 58.58, H 4.81; found C 59.17, H 5.42. 491 
 492 
[Pd(η3-C4H7)(L7)2]PF6 (Pd7′): The procedure was the same as that used to prepare Pd1′. Starting from 493 
L7 (190 mg, 0.57 mmol) and dimer D (43 mg, 0.11 mmol) the desired complex was obtained as a brown 494 
solid, yield 177 mg (83 %). 1H NMR (400 MHz): δ = 7.79 (dd, J = 6.0, 3.2 Hz, 1 H), 7.76 (d, J = 7.2 Hz, 495 
1 H), 7.68–7.63 (m, 2 H), 7.58–7.43 (m, 4 H), 7.39–7.14 (m, 11 H), 7.12 (d, J = 8.0 Hz, 1 H), 6.74 (dd, J 496 
= 7.2, 4.0 Hz, 1 H), 6.69–6.59 (m, 2 H), 6.31 (t, J = 8.8 Hz, 1 H), 5.11 (s, 1 Hs), 4.72 (s, 1 Hs), 3.75 (d, 497 
3JH,P = 10.0 Hz, 1 Ha), 3.72 (d, 3JH,P = 10.4 Hz, 1 Ha), 2.35 (s, 3 H), 1.18 (d, 3JH,P = 15.6 Hz, 9 H), 498 
1.03 (d, 3JH,P = 15.2 Hz, 9 H) ppm. 13C{1H} NMR (101 MHz): δ = 155.7–111.3 (C, CH, Ar), 73.4 (d, 499 
JC,P = 27.5 Hz, CH2), 72.4 (d, JC,P = 28.5 Hz, CH2), 36.9 (d, 1JC,P = 20.6 Hz, C), 35.9 (d, 1JC,P = 500 
21.0 Hz, C), 29.8 (d, 2JC,P = 5.9 Hz, CH3), 29.5 (d, 2JC,P = 6.6 Hz, CH3), 23.0 (s, CH3) ppm. 501 
31P{1H} NMR (162 MHz): δ = +44.4 (d, 2JP,P = 30.5 Hz), +43.8 (d, 2JP,P = 30.9 Hz) ppm. IR: ν˜ = 502 
3062, 2962, 2869, 1583, 1470, 1449, 1398, 1366, 1264, 1185, 1110, 1094, 1011, 830 [ν(PF6 –)], 753, 503 
699, 557 cm–1. C48H49F6O2P3Pd (971.22): calcd. C 59.36, H 5.08; found C 58.90, H 5.52. 504 
 505 
[Pd(η3-C4H7)(L8)2]PF6 (Pd8′): The procedure was the same as that used to prepare Pd1′. Starting from 506 
L8 (126 mg, 0.27 mmol) and dimer D (21 mg, 0.053 mmol) the desired complex was obtained as a 507 
brown solid, yield 115 mg (88 %). 1H NMR (400 MHz): δ = 8.17 (d, J = 7.6 Hz, 1 H), 8.15 (d, J = 7.2 508 
Hz, 1 H), 7.98 (d, J = 7.6 Hz, 1 H), 7.95 (d, J = 7.2 Hz, 1 H), 7.79 (t, J = 6.4 Hz, 2 H), 7.72–7.68 (m, 3 509 
H), 7.64–7.56 (m, 4 H), 7.41–7.32 (m, 5 H), 7.17 (d, J = 8.0 Hz, 1 H), 7.13 (d, J = 8.0 Hz, 1 H), 6.54 (t, J 510 
= 7.6 Hz, 1 H), 6.49 (t, J = 7.6 Hz, 1 H), 6.19 (t, J = 8.8 Hz, 1 H), 6.09 (t, J = 8.8 Hz, 1 H), 4.58 (s, 1 H), 511 
4.47 (s, 1 H), 4.40 (s, 1 H), 4.38 (s, 1 H), 4.31 (s, 2 H), 3.96 (s, 1 H), 3.93 (s, 1 Hs), 3.89 (s, 1 H), 3.83 512 
(s, 1 Hs), 3.72 (s, 5 H), 3.55 (s, 5 H), 3.47 (d, 3JH,P = 10.0 Hz, 1 Ha), 3.20 (d, 3JH,P = 10.0 Hz, 1 Ha), 513 
1.86 (s, 3 H) ppm. 13C{1H} NMR (101 MHz): δ = 155.2–111.5 (C, CH, Ar), 77.8 (d, JC,P = 27.9 Hz, 514 
CH2), 74.0 (s, CH2), 73.9–69.7 (m, 8 × CH), 69.5 (s, 5 × CH), 69.3 (s, 5 × CH), 23.4 (s, CH3) ppm. 515 
31P{1H} NMR (162 MHz): δ = +13.3 (d, 2JP,P = 38.1 Hz), +12.9 (d, 2JP,P = 37.7 Hz) ppm. IR: ν˜ = 516 
3062, 2956, 1585, 1450, 1437, 1402, 1185, 1162, 1108, 1031, 1002, 839 [ν(PF6 –)], 754, 696, 557 cm–517 
1. HRMS: calcd. for C60H49Fe2O2P2Pd [M – PF6] 1081.0935; found 1081.0927. 518 
 519 
[Pd(η3-C4H7)(L10)2]PF6 (Pd10′): The procedure was the same as that used to prepare Pd1′. Starting 520 
from L10 (370 mg, 1.21 mmol) and dimer D (95 mg, 0.24 mmol) the desired complex was obtained as a 521 
brownish solid, yield 350 mg (79 %). 1H NMR (400 MHz): δ = 8.18–8.12 (m, 4 H), 7.74–7.72 (m, 1 H), 522 
7.66–7.64 (m, 1 H), 7.55–7.31 (m, 13 H), 7.23 (td, J = 7.6, 2.4 Hz, 2 H), 7.17–7.09 (m, 3 H), 3.92 (br. s, 523 
1 Hs), 3.72 (br. s, 1 Hs), 3.61 (d, 3JH,P = 9.6 Hz, 1 Ha), 3.51 (d, 3JH,P = 9.6 Hz, 1 Ha), 2.08 (d, 2JH,P = 524 
8.4 Hz, 3 H), 1.92 (s, 3 H), 1.90 (d, 2JH,P = 8.4 Hz, 3 H) ppm. 13C{1H} NMR (101 MHz): δ = 142.6–525 
122.0 (C, CH, Ar), 76.2 (d, JC,P = 28.9 Hz, CH2), 74.9 (d, JC,P = 29.1 Hz, CH2), 23.6 (s, CH3), 13.5 526 
(d, 1JC,P = 27.9 Hz, CH3), 12.6 (d, 1JC,P = 27.2 Hz, CH3) ppm. 31P{1H} NMR (162 MHz): δ = +3.3 527 
(d, 2JP,P = 38.2 Hz), +1.1 (d, 2JP,P = 38.4 Hz) ppm. IR: ν˜ = 3057, 1621, 1437, 1377, 1296, 1251, 528 
1161, 1106, 1078, 839 [ν(PF6 –)], 753, 693, 557 cm–1. C42H37F6P3PdS2 (919.18): calcd. C 54.88, H 529 
4.06, S 6.98; found C 55.08, H 4.33, S 7.02.  530 
 531 
[Pd(η3-C4H7)(L11)2]PF6 (Pd11′): The procedure was the same as that used to prepare Pd1′. Starting 532 
from L11 (733 mg, 2.19 mmol) and dimer D (166 mg, 0.42 mmol) the desired complex was obtained as 533 
a brown solid, yield 310 mg (38 %). 1H NMR (400 MHz): δ = 8.28 (t, J = 8.8 Hz, 2 H), 8.18 (t, J = 8.4 534 
Hz, 2 H), 7.63–7.44 (m, 10 H), 7.37–7.32 (m, 3 H), 7.24–7.08 (m, 7 H), 4.43 (s, 1 Hs), 4.24 (s, 1 Hs), 535 
3.77 (d, 3JH,P = 9.2 Hz, 1 Ha), 3.53 (d, 3JH,P = 9.6 Hz, 1 Ha), 2.57 (m, 2 H), 1.96 (s, 3 H), 0.90–0.76 536 
(m, 9 H), 0.66 (dd, J = 18.0, 6.8 Hz, 3 H) ppm. 13C{1H} NMR (101 MHz): δ = 143.0–121.9 (C, CH, 537 
Ar), 76.9 (d, JC,P = 32.0 Hz, CH2), 75.5 (d, JC,P = 28.2 Hz, CH2), 27.1 (d, 1JC,P = 21.2 Hz, CH), 26.6 538 
(d, 1JC,P = 21.9 Hz, CH), 22.9 (s, CH3), 18.9 (d, 2JC,P = 4.4 Hz, CH3), 18.5 (s, 3CH3) ppm. 31P{1H} 539 
NMR (162 MHz): δ = +26.6 (d, 2JP,P = 32.6 Hz), +24.9 (d, 2JP,P = 32.6 Hz) ppm. IR: ν˜ = 3057, 2962, 540 
2930, 2870, 1585, 1437, 1375, 1250, 1098, 1078, 1033, 839 [ν(PF6 –)], 755, 703, 557 cm–1. 541 
C46H45F6P3PdS2 (975.29): calcd. C 56.65, H 4.65, S 6.57; found C 56.90, H 5.33, S 6.06. 542 
 543 
[Pd(η3-C4H7)(L12)2]PF6 (Pd12′): The procedure was the same as that used to prepare Pd1′. Starting 544 
from L12 (100 mg, 0.21 mmol) and dimer D (17 mg, 0.043 mmol) the desired complex was obtained as 545 
a brown solid, yield 88 mg (93 %). 1H NMR (400 MHz): δ = 8.03 (t, J = 6.8 Hz, 2 H), 7.90 (t, J = 8.8 546 
Hz, 2 H), 7.72 (t, J = 8.4 Hz, 2 H), 7.61 (t, J = 9.2 Hz, 2 H), 7.53–7.34 (m, 12 H), 7.20–6.97 (m, 4 H), 547 
4.49 (s, 1 H), 4.40 (s, 1 H), 4.35 (s, 2 H), 4.30 (s, 1 H), 4.23 (s, 1 Hs), 4.13 (s, 1 Hs), 4.02 (s, 2 H), 3.96 548 
(s, 1 H), 3.87 (s, 5 H), 3.85 (s, 5 H), 3.74 (d, 3JH,P = 12.8 Hz, 1 Ha), 3.71 (d, 3JH,P = 9.6 Hz, 1 Ha), 549 
2.10 (s, 3 H) ppm. 31P{1H} NMR (162 MHz): δ = +15.0 (d, 2JP,P = 32.2 Hz), +14.3 (d, 2JP,P = 32.6 550 
Hz) ppm. IR: ν˜ = 3057, 2957, 1437, 1402, 1376, 1161, 1107, 1033, 840 [ν(PF6 –)], 754, 696, 557 cm–551 
1. HRMS: calcd. For C60H49Fe2P2PdS2 [M – PF6] 1113.0479; found 1113.0479. 552 
 553 
[Pd(η3-C4H7)(L13)2]PF6 (Pd13′): The procedure was the same as that used to prepare Pd1′. Starting 554 
from L13 (240 mg, 0.71 mmol) and dimer D (56 mg, 0.14 mmol) the desired complex was obtained as a 555 
yellow solid, yield 210 mg (76 %). 1H NMR (400 MHz): δ = 8.00–6.80 (m, 24 H), 3.73 (br. s, 2 Hs), 556 
3.49 (br. s, 1 Ha), 3.25 (br. s, 1 Ha), 2.03 (s, 3 H), 2.00 (s, 3 H) ppm. 31P{1H} NMR (162 MHz): δ = 557 
+3.4 (d, 2JP,P = 39.7 Hz), +1.5 (d, 2JP,P = 41.1 Hz) ppm. IR: ν˜ = 3053, 2957, 2919, 1449, 1434, 1381, 558 
1141, 1110, 1028, 888, 832 [ν(PF6 –)], 748, 693, 557 cm–1. HRMS: calcd. for C23H22PPdS2 [M – PF6 559 
– L13] 498.9935; found 498.9950. 560 
 561 
[Pd(η3-C4H7)(κ2P,S-L3)]PF6 (Pd3′′): Complex Pd3 (148 mg, 0.27 mmol) was dissolved in 562 
dichloromethane (20 mL), thallium hexafluorophosphate (101 mg, 0.29 mmol) was added, and the pale 563 
yellow suspension was stirred for 2 h. Water (20 mL) was added and the mixture was extracted with 564 
dichloromethane (3 × 10 mL). The combined organic phases were washed with water, dried with 565 
anhydrous sodium sulfate and filtered, and the solvent was removed under vacuum. The crude product 566 
was recrystallised from dichloromethane/ hexane, yield 120 mg (67 %). 1H NMR (400 MHz): δ = 7.89–567 
7.87 (d, J = 7.2 Hz, 2 H, m + M), 7.73–7.70 (m, 5 H, m + M), 7.64–7.41 (m, 17 H, m + M), 5.36 (br. s, 1 568 
Hts, m), 5.31 (br. s, 1 Hts, M), 4.64 (s, 1 Hcs, m), 4.31 (s, 1 Hcs, M), 4.20 (d, J = 12.0 Hz, 1 Hta, M), 569 
4.11 (d, J = 10.4 Hz, 1 Hta, m), 3.84 (s, 1 Hca, M), 3.78 (d, 3JH,P = 15.6 Hz, 3 H, M), 3.60 (d, 3JH,P = 570 
15.6 Hz, 3 H, m), 3.35 (s, 1 Hca, m), 2.14 (s, 3 H, m), 1.98 (s, 3 H, M) ppm. 13C{1H} NMR (101 571 
MHz): δ = 139.6–129.3 (C, CH, Ar), 78.9 (d, 2JC,P = 29.8 Hz, CH2 t, m), 78.4 (d, 2JC,P = 32.4 Hz, 572 
CH2 t, M), 66.1 (s, CH2 c, M), 65.7 (s, CH2 c, m), 58.1 (s, CH3, M), 57.5 (s, CH3, m), 24.1 (s, CH3, 573 
M), 23.9 (s, CH3, m) ppm. 31P{1H} NMR (162 MHz): δ = +138.5 (br. s, m), 136.2 (s, M) ppm. IR: ν˜ = 574 
3058, 2944, 1436, 1386, 1143, 1109, 1026, 832 [ν(PF6 –)], 778, 751, 715, 693, 557, 505 cm–1. 575 
C23H22F6OP2PdS2 (660.88): calcd. C 41.80, H 3.35, S 9.70; found C 41.87, H 3.61, S 9.99. 576 
 577 
[Pd(η3-C4H7)(κ2P,S-L13)]BF4 (Pd13′′): The procedure was the same as that followed to prepare Pd3′′. 578 
Starting from Pd13 (150 mg, 0.28 mmol) and TlBF4 (87 mg, 0.30 mmol), the desired complex was 579 
obtained as a yellow solid, yield 110 mg (67 %). 1H NMR (400 MHz): δ = 7.83 (d, J = 7.6 Hz, 1 H, M), 580 
7.82 (d, J = 7.8 Hz, 1 H, m), 7.72–7.65 (m, 5 H, m + M), 7.64–7.43 (m, 17 H, m + M), 5.28 (br. s, 1 Hts, 581 
m), 5.21 (br. s, 1 Hts, M), 4.75 (s, 1 Hcs, m), 4.26 (s, 1 Hcs, M), 4.05 (d, J = 10.0 Hz, 1 Hta, M), 3.88 (d, 582 
J = 10.0 Hz, 1 Hta, m), 3.77 (s, 1 Hca, M), 3.20 (s, 1 Hca, m), 2.35 (d, 2JH,P = 10.0 Hz, 3 H, M), 2.30 583 
(d, 2JH,P = 10.0 Hz, 3 H, m), 2.14 (s, 3 H, m), 1.96 (s, 3 H, M) ppm. 13C{1H} NMR (101 MHz): δ = 584 
139.8–129.5 (C, CH, Ar), 77.0 (d, 2JC,P = 31.7 Hz, CH2 t, m), 76.7 (d, 2JC,P = 31.3 Hz, CH2 t, M), 585 
67.0 (s, CH2 c, M), 66.4 (s, CH2 c, m), 24.0 (s, CH3, M), 23.8 (s, CH3, m), 14.4 (d, 1JC,P = 28.7 Hz, 586 
CH3, m), 12.9 (d, 1JC,P = 28.3 Hz, CH3, M) ppm. 31P{1H} NMR (162 MHz): δ = +35.4 (s, M), 34.2 587 
(s, m) ppm. IR: ν˜ = 3056, 2958, 2918, 1436, 1385, 1283, 1046 [ν(BF4 –)], 894, 838, 789, 751, 714, 588 
693, 556, 534, 521, 499, 462, 435 cm–1. C23H22BF4PPdS2 (586.72): calcd. C 47.08, H 3.78, S 10.93; 589 
found C 46.89, H 4.05, S 10.41. 590 
 591 
Catalytic Procedures 592 
Pd-Catalysed Hydrovinylation: Hydrovinylation reactions were carried out in a stainless steel autoclave 593 
fitted with an external jacket connected to an ethanol bath, with the temperature controlled by thermostat 594 
to ± 0.5 °C. The internal temperature was monitored with a thermocouple. The Pd precursor (0.020 595 
mmol), styrene (2.08 g, 20 mmol) and AgBF4 (4.3 mg, 0.022 mmol) were dissolved in dichloromethane 596 
(15 mL) and stirred for 10 min, protected from light. After the AgCl produced had been filtered off, the 597 
solution was quickly placed, by syringe, into the autoclave, which had been purged by successive 598 
vacuum/nitrogen cycles and was thermostatted to 25 °C. Ethylene was admitted until a pressure of 599 
around 15 bar was reached. After the allotted time, the autoclave was slowly depressurized and aqueous 600 
NH4Cl solution (10 %, 10 mL) was added. The mixture was stirred for 10 min in order to quench the 601 
catalyst. The organic layer was separated, dried with Na2SO4, filtered through a plug of SiO2 and 602 
subjected to GC analysis. 603 
 604 
Pd-Catalysed Allylic Substitutions 605 
(A) Allylic Alkylation with Dimethyl Malonate: The appropriate Pd precursor (0.01 mmol), trans-1,3-606 
diphenylprop-2-enyl acetate (rac-I, 1 mmol), dimethyl malonate (3 mmol), BSA (3 mmol) and KOAc (1 607 
mg) were dissolved, in that precise order, in dichloromethane (5 mL) under nitrogen. The flask was 608 
covered with an aluminium foil and left stirring for the allotted time. To quench the reaction, diethyl 609 
ether (20 mL) and aqueous ammonium chloride solution (10 %, 20 mL) were added. After extraction, 610 
the organic phase was dried with anhydrous sodium sulfate and filtered, and the solvents were removed 611 
in vacuo. The crude product was analysed by 1H NMR to estimate the level of conversion. It was then 612 
dissolved in ethyl acetate and passed through a column of silica to remove the metallic impurities. The 613 
eluent was removed in vacuo and the residue was analysed by NMR and HPLC. 614 
(B) Allylic Amination with Benzylamine: The Pd precursor (0.01 mmol), trans-1,3-diphenylprop-2-enyl 615 
acetate (rac-I, 1 mmol) and benzylamine (3 mmol) were dissolved, in that precise order, in 616 
dichloromethane (5 mL ) under nitrogen. The flask was covered with an aluminium foil and the mixture 617 
was stirred for the allotted time. To quench the reaction, diethyl ether (20 mL) and aqueous ammonium 618 
chloride solution (10 %, 20 mL) were added. After extraction, the organic phase was dried with 619 
anhydrous sodium sulfate and filtered, and the solvents were removed in vacuo. The crude product was 620 
analysed by 1H NMR to estimate the level of conversion. It was then dissolved in ethyl acetate and 621 
passed through a column of silica to remove the metallic impurities. The eluent was removed in vacuo 622 
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Legends to figures 694 
 695 
Scheme 1. P-stereogenic phosphanes containing a heterocyclic substituent. 696 
 697 
Scheme 2. Preparation of neutral palladium complexes Pd1–13. 698 
 699 
Scheme 3. Preparation of cationic Pd complexes Pd1′–13′. 700 
 701 
Scheme 4. Unsuccessful attempts to force κ2P,O- and κ2P,S-coordination in Pd complexes of DBF- and 702 
DBT-based ligands. 703 
 704 
Scheme 5. Successful κ2P,S-coordination in Pd complexes of TA-based ligands. 705 
 706 
Figure 1. ORTEP representation (thermal ellipsoids drawn at 50 % probability level, H atoms and PF6 – 707 
anions removed for clarity) of anti-Pd3′′ (left) and syn-Pd3′′ (right). Interatomic distances [Å] and angles 708 
[°] for anti-Pd3′′: Pd(1A)–C(19A), 2.107(11); Pd(1A)–C(20A), 2.212(10); Pd(1A)–C(21A), 2.211(10); 709 
P(1A)–Pd(1A)–C(19A), 98.9(3); C(19A)–Pd(1A)–C(21A), 65.9(4); C(21A)–Pd(1A)–S(1A), 106.7(3); 710 
S(1A)–Pd(1A)–P(1A), 88.18(9); C(1A)–S(1A)–C(12A), 100.3(4); C(6A)–S(2A)–C(7A), 100.9(5). For 711 
syn-Pd3′′: Pd(1B)–C(19B), 2.238(10); Pd(1B)–C(20B), 2.167(9); Pd(1B)–C(21B), 2.210(11); P(1B)–712 
Pd(1B)–C(21B), 98.8(3); C(21B)–Pd(1B)–C(19B), 66.8(4); C(19B)–Pd(1B)–S(1B), 105.2(3); S(1B)–713 
Pd(1B)–P(1B), 88.65(8); C(1B)–S(1B)–C(12B), 100.4(5); C(6B)–S(2B)–C(7B), 102.0(4). 714 
 715 
Scheme 6 Pd-catalysed enantioselective hydrovinylation of styrene. 716 
 717 
Scheme 7. Pd-catalysed enantioselective allylic substitution on substrate rac-I. 718 
719 






















































Table 2. Results of enantioselective allylic substitutions of rac-I with Pd complexes. 774 
 775 
 776 
 777 
